Inogen financials
$5.37−1.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $95.1M | $85.1M | $81.7M | $92.4M | $92.3M | $82.3M | $80.1M | $88.8M | $88.8M | $78.0M | $75.9M | $84.0M |
| Gross profit | $43.3M | $37.9M | $35.2M | $41.3M | $41.3M | $36.4M | $36.3M | $41.3M | $42.7M | $34.4M | $28.2M | $33.8M |
| Gross margin | 45.5% | 44.5% | 43.1% | 44.7% | 44.8% | 44.2% | 45.3% | 46.5% | 48.1% | 44.1% | 37.1% | 40.2% |
| Operating income | -$5.1M | -$9.3M | -$9.3M | -$7.1M | -$6.1M | -$7.7M | -$11.4M | -$7.8M | -$7.1M | -$16.3M | -$29.0M | -$46.7M |
| Net income | -$3.9M | -$8.3M | -$7.1M | -$5.3M | -$4.2M | -$6.2M | -$9.8M | -$6.0M | -$5.6M | -$14.6M | -$26.6M | -$45.7M |
| Net margin | −4.0% | −9.8% | −8.7% | −5.7% | −4.5% | −7.5% | −12.2% | −6.7% | −6.3% | −18.7% | −35.0% | −54.4% |
| Diluted EPS | $-0.14 | $-0.30 | $-0.26 | $-0.20 | $-0.15 | $-0.25 | $-0.41 | $-0.25 | $-0.24 | $-0.62 | $-1.14 | $-1.97 |
| EBITDA | -$399.0K | -$4.4M | -$4.3M | -$1.9M | -$913.0K | -$2.5M | -$6.3M | -$2.5M | -$1.7M | -$11.0M | -$29.0M | -$9.2M |
| Operating cash flow | $2.9M | -$6.7M | -$943.0K | $2.2M | $4.3M | -$16.8M | -$3.0M | $7.0M | $6.7M | -$4.7M | -$10.0M | $2.2M |
| Free cash flow | $1.0M | -$7.5M | -$6.4M | $64.0K | $480.0K | -$18.8M | -$11.5M | $2.1M | $3.8M | -$8.9M | -$16.3M | -$3.1M |
| Diluted shares | 27.0M | 27.3M | 27.2M | 27.1M | 27.0M | 25.2M | 23.8M | 23.8M | 23.6M | 23.4M | 23.3M | 23.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $87.3M | $93.1M | $103.7M | $106.5M | $103.7M | $118.9M |
| Short-term investments | $18.3M | $17.1M | $15.8M | $16.7M | $18.7M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $285.6M | $285.9M | $298.6M | $307.0M | $312.0M | $308.4M |
| Total liabilities | $110.7M | $103.0M | $106.4M | $109.8M | $112.5M | $110.5M |
| Shareholders' equity | $174.9M | $182.9M | $192.2M | $197.2M | $199.5M | $198.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology